462 related articles for article (PubMed ID: 11826205)
1. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
Durand M; Mendoza ME; Tantivit P; Kugelman A; McEvoy C
Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
[TBL] [Abstract][Full Text] [Related]
2. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
Durand M; Sardesai S; McEvoy C
Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
4. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
Gross SJ; Anbar RD; Mettelman BB
Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
[TBL] [Abstract][Full Text] [Related]
5. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
Yeh TF; Lin YJ; Hsieh WS; Lin HC; Lin CH; Chen JY; Kao HA; Chien CH
Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536
[TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Marr BL; Mettelman BB; Bode MM; Gross SJ
J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
[TBL] [Abstract][Full Text] [Related]
7. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants.
Vento G; Matassa PG; Zecca E; Tortorolo L; Martelli M; De Carolis MP; Maggio L; Zini G; D'Onofrio G; Valentini S; Romagnoli C
Pharmacology; 2004 Jul; 71(3):113-9. PubMed ID: 15161992
[TBL] [Abstract][Full Text] [Related]
8. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
Vermont Oxford Network Steroid Study Group
Pediatrics; 2001 Sep; 108(3):741-8. PubMed ID: 11533345
[TBL] [Abstract][Full Text] [Related]
9. Early dexamethasone-attempting to prevent chronic lung disease.
Sinkin RA; Dweck HS; Horgan MJ; Gallaher KJ; Cox C; Maniscalco WM; Chess PR; D'Angio CT; Guillet R; Kendig JW; Ryan RM; Phelps DL
Pediatrics; 2000 Mar; 105(3 Pt 1):542-8. PubMed ID: 10699107
[TBL] [Abstract][Full Text] [Related]
10. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia.
Pappagallo M; Abbasi S; Bhutani VK
Indian J Pediatr; 1998; 65(2):273-82. PubMed ID: 10771973
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
Brundage KL; Mohsini KG; Froese AB; Walker CR; Fisher JT
Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
13. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
Shenai JP; Mellen BG; Chytil F
Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
[TBL] [Abstract][Full Text] [Related]
14. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
[TBL] [Abstract][Full Text] [Related]
15. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray.
Schrod L; Neuhaus T; Horwitz AE; Speer CP
Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
[TBL] [Abstract][Full Text] [Related]
18. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial.
Garland JS; Alex CP; Pauly TH; Whitehead VL; Brand J; Winston JF; Samuels DP; McAuliffe TL
Pediatrics; 1999 Jul; 104(1 Pt 1):91-9. PubMed ID: 10390266
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity.
Kovács L; Davis GM; Faucher D; Papageorgiou A
Acta Paediatr; 1998 Jul; 87(7):792-8. PubMed ID: 9722255
[TBL] [Abstract][Full Text] [Related]
20. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
